Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Oct 6 · above the Ichimoku cloud · RSI 68 · MACD above its signal · at its 52-week high
None of the 29 investors followed here reported a position in BIMI in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a BIMI trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for BIMI.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 150.0 | +400.0% | ||
| 2025 | -90.9 | 0.0 | 100.0 | 400.0 | -70.0 | -66.7 | 100.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | −90.9% |
| 2024 | 26.3 | 40.0 | -56.6 | -29.2 | -3.4 | 11.3 | -67.2 | -95.2 | -72.5 | 263.6 | -62.5 | -85.3 | −99.9% |
| 2023 | 22.0 | -16.7 | -56.1 | 56.7 | 15.1 | 41.4 | 142.9 | -30.0 | -34.0 | -8.9 | 36.4 | 12.3 | +78.0% |
| 2022 | -21.6 | -38.0 | 11.3 | -29.4 | -57.4 | 53.9 | -16.6 | -7.7 | -42.4 | -8.4 | -13.6 | -45.2 | −95.2% |
| 2021 | 13.2 | -6.9 | -0.6 | -14.9 | -16.1 | 7.2 | -10.4 | -30.8 | -13.4 | 15.8 | 0.8 | -39.2 | −69.5% |
| 2020 | 56.1 | -18.3 | -39.1 | 6.0 | -6.5 | -7.7 | -16.7 | -5.3 | -6.1 | 7.1 | 5.6 | -12.1 | −47.6% |
| 2019 | -55.9 | -10.2 | -0.3 | -36.7 | -22.8 | -21.8 | -2.5 | -7.0 | -49.3 | 322.9 | -43.0 | 21.3 | −79.7% |
| 2018 | 6.2 | -13.6 | 59.5 | -14.8 | 105.0 | 8.1 | 60.6 | -0.8 | 10.1 | 41.3 | 56.3 | 51.5 | +1521.6% |
| 2017 | 32.9 | -10.0 | 6.3 | 0.9 | -22.5 | 5.8 | -2.2 | -10.1 | 16.3 | -3.2 | 15.9 | -7.0 | +12.1% |
| 2016 | -4.1 | 5.0 | 0.8 | -5.5 | 1.2 | 5.7 | 74.9 | -19.1 | 8.5 | -12.2 | -9.9 | -4.9 | +18.5% |
| 2015 | 23.9 | 0.5 | -11.6 | 17.7 | -21.4 | -4.3 | -8.8 | -23.3 | 13.4 | -14.2 | -17.5 | -16.1 | −54.1% |
| 2014 | 0.6 | 5.6 | -5.3 | -30.0 | -0.9 | 138.8 | -7.9 | 30.3 | -11.9 | -14.4 | -17.5 | -19.7 | −0.0% |
| 2013 | -8.2 | -1.5 | -9.8 | -14.7 | 4.2 | -13.4 | 1.7 | 196.9 | -2.6 | -14.9 | 1.0 | -1.6 | +56.3% |
| 2012 | -14.4 | 52.6 | 8.0 | 105.3 | -35.2 | -8.0 | -27.0 | 7.1 | -23.2 | 6.0 | 52.9 | -9.2 | +52.7% |
| 2011 | -10.2 | -6.5 | -22.5 | -9.5 | -19.7 | -30.1 | 28.7 | -43.7 | -36.6 | 6.4 | -8.1 | -10.6 | −86.7% |
| 2010 | -12.4 | -13.0 | 25.0 | -10.0 | -19.4 | -12.1 | 7.8 | -9.1 | 4.0 | -16.2 | -19.3 | 13.9 | −52.3% |
| 2009 | -22.0 | 2.6 | 173.8 | -17.8 | 344.4 | 6.2 | 92.9 | 11.8 | -16.4 | -17.8 | 8.2 | 2.7 | +1300.0% |
| 2008 | 0.0 | 60.0 | -47.5 | -9.5 | 63.2 | 3.2 | 0.0 | 0.0 | 6.3 | -26.5 | -50.4 | -19.3 | −60.0% |
| 2007 | 0.0 | 0.0 | 0.0 | 47.1 | -6.7 | -27.1 | -21.6 | 0.0 | 0.0 | 62.5 | -46.2 | -28.6 | −51.0% |
No analyst coverage for this instrument.
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items. The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items. The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products. It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. The company was incorporated in 2000 and is based in New York, New York.
No recent headlines.